A major advance in the understanding of COPA syndrome pathogenesis came from the observation of an enhanced expression of interferon (IFN)-stimulated genes (ISGs) in the whole blood of symptomatic individuals, a hallmark of the type I interferonopathies [3]. This evidence concerns the gene IFNA1 and autoimmune interstitial lung disease-arthritis syndrome.